Jefferies Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $42.9M | Buy |
84,500
+2,600
| +3% | +$1.46M | 0.36% | 46 |
|
|
2022
Q2 | $44.5M | Buy |
81,900
+7,500
| +10% | +$4.13M | 0.37% | 45 |
|
|
2022
Q1 | $43.9M | Sell |
74,400
-77,700
| -51% | -$44.6M | 0.28% | 54 |
|
|
2021
Q4 | $101M | Buy |
152,100
+74,400
| +96% | +$46.5M | 0.59% | 24 |
|
|
2021
Q3 | $44.4M | Buy |
77,700
+76,000
| +4,471% | +$41.7M | 0.32% | 46 |
|
|
2021
Q2 | $858K | Hold |
1,700
| – | – | 0.01% | 1035 |
|
|
2021
Q1 | $776K | Sell |
1,700
-17,400
| -91% | -$8.31M | 0.01% | 978 |
|
|
2020
Q4 | $8.9M | Buy |
19,100
+1,700
| +10% | +$797K | 0.07% | 247 |
|
|
2020
Q3 | $7.68M | Buy |
17,400
+13,500
| +346% | +$5.58M | 0.09% | 194 |
|
|
2020
Q2 | $1.41K | Sell |
3,900
-3,000
| -43% | -$1.01M | 0.02% | 676 |
|
|
2020
Q1 | $1.96M | Buy |
6,900
+400
| +6% | +$126K | 0.02% | 700 |
|
|
2019
Q4 | $2.11M | Buy |
6,500
+6,200
| +2,067% | +$1.88M | 0.02% | 1023 |
|
|
2019
Q3 | $87K | Sell |
300
-1,900
| -86% | -$544K | ﹤0.01% | 2530 |
|
|
2019
Q2 | $646K | Sell |
2,200
-6,800
| -76% | -$1.87M | ﹤0.01% | 1532 |
|
|
2019
Q1 | $2.46M | Buy |
9,000
+2,700
| +43% | +$672K | 0.02% | 799 |
|
|
2018
Q4 | $1.41M | Sell |
6,300
-800
| -11% | -$188K | 0.01% | 991 |
|
|
2018
Q3 | $1.73M | Buy |
7,100
+6,200
| +689% | +$1.43M | 0.01% | 1050 |
|
|
2018
Q2 | $186K | Sell |
900
-17,600
| -95% | -$3.74M | ﹤0.01% | 2047 |
|
|
2018
Q1 | $3.82M | Buy |
18,500
+14,900
| +414% | +$3.13M | 0.02% | 578 |
|
|
2017
Q4 | $684K | Sell |
3,600
-1,700
| -32% | -$326K | ﹤0.01% | 1578 |
|
|
2017
Q3 | $1M | Sell |
5,300
-26,900
| -84% | -$4.87M | 0.01% | 1291 |
|
|
2017
Q2 | $5.62M | Buy |
32,200
+19,200
| +148% | +$3.22M | 0.04% | 482 |
|
|
2017
Q1 | $2M | Buy |
13,000
+12,700
| +4,233% | +$1.94M | 0.01% | 915 |
|
|
2016
Q4 | $42K | Sell |
300
-14,900
| -98% | -$2.2M | ﹤0.01% | 2093 |
|
|
2016
Q3 | $2.42M | Buy |
+15,200
| New | +$2.34M | 0.01% | 841 |
|
|
2016
Q2 | – | Sell |
-7,600
| Closed | -$1.08M | – | 2443 |
|
|
2016
Q1 | $1.08M | Buy |
7,600
+5,000
| +192% | +$670K | 0.01% | 1109 |
|
|
2015
Q4 | $369K | Buy |
+2,600
| New | +$347K | ﹤0.01% | 1687 |
|
|
2014
Q3 | – | Sell |
-62,500
| Closed | -$7.38M | – | 2433 |
|
|
2014
Q2 | $7.38M | Hold |
62,500
| – | – | 0.06% | 273 |
|
|
2014
Q1 | $7.51M | Buy |
62,500
+51,400
| +463% | +$6.11M | 0.07% | 213 |
|
|
2013
Q4 | $1.24M | Hold |
11,100
| – | – | 0.01% | 743 |
|
|
2013
Q3 | $1.02M | Buy |
+11,100
| New | +$1M | 0.01% | 898 |
|
Other funds holding TMO
Jefferies Group's TMO Position: Q3 2022 in Review
Jefferies Group increased its Thermo Fisher Scientific (TMO) stake by 24% in Q3 2022, buying an estimated $5.2M and bringing the position to 48,688 shares worth $24.7M. The position accounts for 0.21% of the portfolio, ranked #74.
Jefferies Group first reported a position in TMO in Q2 2013 and has held it in 36 quarters since. The position peaked at $27.6M in Q1 2022. 2,266 funds tracked by Wall St. Rank hold TMO as of Q3 2022.
- Jefferies Group held 48,688 shares of Thermo Fisher Scientific worth $24.7M as of Q3 2022.
- Jefferies Group bought 9,295 Thermo Fisher Scientific shares in Q3 2022, an estimated $5.2M.
- Thermo Fisher Scientific made up 0.21% of Jefferies Group's portfolio in Q3 2022, its #74 holding.
- Jefferies Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 36 quarters since.
- Jefferies Group's Thermo Fisher Scientific position peaked at $27.6M in Q1 2022.
- 2,266 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.